Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract 4389: Impact of regulatory T cell depletion on dendritic cell-tumor fusion vaccine immunotherapy

Chunrui Tan, Varun Reddy, Enyu Ding, Jens Dannull, Smita Nair, Scott K. Pruitt, Walter T. Lee

Cancer Res (2012) 72 (8_Supplement): 4389.

https://doi.org/10.1158/1538-7445.AM2012-4389

Published: 15 April 2012

View articletitled, Abstract 4389: Impact of regulatory T cell depletion on dendritic cell-tumor fusion vaccine immunotherapy

Journal Articles

Abstract 5373: Altering the composition of the proteasome of melanoma antigen RNA-transfected dendritic cells enhances vaccination-induced anti-melanoma immunity: results of a Phase I trial

Jens Dannull, N. Rebecca Haley, Gary Archer, Smita Nair, Nicole De Rosa, Maria Selim, Douglas S. Tyler, John Sampson, Scott K. Pruitt

Cancer Res (2012) 72 (8_Supplement): 5373.

https://doi.org/10.1158/1538-7445.AM2012-5373

Published: 15 April 2012

View articletitled, Abstract 5373: Altering the composition of the proteasome of melanoma antigen RNA-transfected dendritic cells enhances vaccination-induced anti-melanoma immunity: results of a Phase I trial

Journal Articles

TIE-2 is a promising anti-angiogenic target for immunotherapy of renal cell cancer

Jens Dannull, Hubert R. Kuebler, Timothy T. Tseng, Philipp Dahm, Aijing Zhang, Johannes Vieweg

Cancer Res (2006) 66 (8_Supplement): 278.

Published: 15 April 2006

View articletitled, TIE-2 is a promising anti-angiogenic target for immunotherapy of renal cell cancer

Journal Articles

In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy

Hubert R. Kuebler, Philipp Dahm, Timothy T. Tseng, Aijing Zhang, Doris Coleman, Johannes Vieweg, Jens Dannull

Cancer Res (2006) 66 (8_Supplement): 941.

Published: 15 April 2006

View articletitled, In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy

Journal Articles

Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Jens Dannull, Hubert R. Kuebler, Timothy T. Tseng, Aijing Zhang, Zhen Su, Philipp Dahm, Johannes Vieweg

Cancer Res (2006) 66 (8_Supplement): 909.

Published: 15 April 2006

View articletitled, Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Journal Articles

Reversal of immature myeloid cell-mediated immunosuppression

Curtis Bradney, Jens Dannull, Zhen Su, Aijing Zhang, Johannes Vieweg

Cancer Res (2005) 65 (9_Supplement): 569.

Published: 01 May 2005

View articletitled, Reversal of immature myeloid cell-mediated immunosuppression

Journal Articles

Delivery of mRNA into human dendritic cells using novel transfer peptides leads to prolonged antigen expression and potent immune responses in vivo

Zhen Su, Quinton Cancel, Philip Dahm, Johannes Vieweg, Jens Dannull

Cancer Res (2005) 65 (9_Supplement): 996.

Published: 01 May 2005

View articletitled, Delivery of mRNA into human dendritic cells using novel transfer peptides leads to prolonged antigen expression and potent immune responses in vivo

Journal Articles

Co-transfection of immature DC with RNA encoding TLR4 combined with MART-1 RNA induces DC maturation and enhances the immunogenicity of MART-1 RNA

Zeinab Abdel-Wahab, Robin Cisco, Jens Dannull, Matthew F. Kalady, Mark W. Onaitis, Douglas S. Tyler, Scott K. Pruitt

Cancer Res (2004) 64 (7_Supplement): 291.

Published: 01 April 2004

View articletitled, Co-transfection of immature DC with RNA encoding TLR4 combined with MART-1 RNA induces DC maturation and enhances the immunogenicity of MART-1 RNA

Journal Articles

Enhanced antigen presenting function of antigen-loaded dendritic cells following cotransfection with OX40 ligand mRNA.

Jens Dannull, Smita Nair, Zhen Su, Eli Gilboa, Johannes Vieweg

Cancer Res (2004) 64 (7_Supplement): 495.

Published: 01 April 2004

View articletitled, Enhanced antigen presenting function of antigen-loaded dendritic cells following cotransfection with OX40 ligand mRNA.

Journal Articles

Enhancement of antitumor immunity following depletion of CD4⁺CD25⁺ regulatory T cells.

Jens Dannull, Benjamin K. Yang, Zhen Su, Johannes Vieweg

Cancer Res (2004) 64 (7_Supplement): 503.

Published: 01 April 2004

View articletitled, Enhancement of antitumor immunity following depletion of CD4+CD25+ regulatory T cells.

Journal Articles

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results From A Phase I clinical trial

Zhen Su, Benjamin K. Yang, Jens Dannull, Philipp Dahm, Johannes Vieweg

Cancer Res (2004) 64 (7_Supplement): 325.

Published: 01 April 2004

View articletitled, Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results From A Phase I clinical trial

Journal Articles

Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells

Zhen Su, Jens Dannull, Axel Heiser, Donna Yancey, Scott Pruitt, John Madden, Doris Coleman, Donna Niedzwiecki, Eli Gilboa, Johannes Vieweg

Cancer Res (2003) 63 (9): 2127–2133.

Published: 01 May 2003

View articletitled, Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells

Journal Articles

Enhanced Induction of Telomerase-specific CD4⁺ T Cells Using Dendritic Cells Transfected with RNA Encoding a Chimeric Gene Product

Zhen Su, Johannes Vieweg, Alon Z. Weizer, Philipp Dahm, Donna Yancey, Vandana Turaga, John Higgins, David Boczkowski, Eli Gilboa, Jens Dannull

Cancer Res (2002) 62 (17): 5041–5048.

Published: 01 September 2002

View articletitled, Enhanced Induction of Telomerase-specific CD4+ T Cells Using Dendritic Cells Transfected with RNA Encoding a Chimeric Gene Product

Journal Articles

Prostate Stem Cell Antigen Is a Promising Candidate for Immunotherapy of Advanced Prostate Cancer

Jens Dannull, Pierre-André Diener, Ladislav Prikler, Gregor Fürstenberger, Thomas Cerny, Ulrico Schmid, Daniel K. Ackermann, Marcus Groettrup

Cancer Res (2000) 60 (19): 5522–5528.

Published: 01 October 2000

View articletitled, Prostate Stem Cell Antigen Is a Promising Candidate for Immunotherapy of Advanced Prostate Cancer

Journal Articles

Highly Efficient and Consistent Gene Transfer into Dendritic Cells Utilizing a Combination of Ultraviolet-irradiated Adenovirus and Poly(l-Lysine) Conjugates¹

Peter Mulders, Shen Pang, Jens Dannull, Randhir Kaboo, Andreas Hinkel, Kiarash Michel, Cho-Lea Tso, Michael Roth, Arie Belldegrun

Cancer Res (1998) 58 (5): 956–961.

Published: 01 March 1998

View articletitled, Highly Efficient and Consistent Gene Transfer into Dendritic Cells Utilizing a Combination of Ultraviolet-irradiated Adenovirus and Poly(l-Lysine) Conjugates1

Journal Articles

Identification of a Positive Regulatory Element Responsible for Tissue-specific Expression of Prostate-specific Antigen

Shen Pang, Jens Dannull, Randhir Kaboo, Yiming Xie, Cho-Lea Tso, Kiarash Michel, Jean B. deKernion, Arie S. Belldegrun

Cancer Res (1997) 57 (3): 495–499.

Published: 01 February 1997

View articletitled, Identification of a Positive Regulatory Element Responsible for Tissue-specific Expression of Prostate-specific Antigen

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 4389: Impact of regulatory T cell depletion on dendritic cell-tumor fusion vaccine immunotherapy

Abstract 5373: Altering the composition of the proteasome of melanoma antigen RNA-transfected dendritic cells enhances vaccination-induced anti-melanoma immunity: results of a Phase I trial

TIE-2 is a promising anti-angiogenic target for immunotherapy of renal cell cancer

In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy

Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Reversal of immature myeloid cell-mediated immunosuppression

Delivery of mRNA into human dendritic cells using novel transfer peptides leads to prolonged antigen expression and potent immune responses in vivo

Co-transfection of immature DC with RNA encoding TLR4 combined with MART-1 RNA induces DC maturation and enhances the immunogenicity of MART-1 RNA

Enhanced antigen presenting function of antigen-loaded dendritic cells following cotransfection with OX40 ligand mRNA.

Enhancement of antitumor immunity following depletion of CD4⁺CD25⁺ regulatory T cells.

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results From A Phase I clinical trial

Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells

Enhanced Induction of Telomerase-specific CD4⁺ T Cells Using Dendritic Cells Transfected with RNA Encoding a Chimeric Gene Product

Prostate Stem Cell Antigen Is a Promising Candidate for Immunotherapy of Advanced Prostate Cancer

Highly Efficient and Consistent Gene Transfer into Dendritic Cells Utilizing a Combination of Ultraviolet-irradiated Adenovirus and Poly(l-Lysine) Conjugates¹

Identification of a Positive Regulatory Element Responsible for Tissue-specific Expression of Prostate-specific Antigen

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only